Study Hints of Rituximab MS Benefit MedPage Today Among 25 patients with secondary progressive MS treated with rituximab, nine showed decreases in disability and 12 appeared to stabilize after receiving at least two cycles of rituximab given every 3 months, said Christopher Perrone, a fourth-year ... |
